Novavax (NASDAQ:NVAX) was on monitor to finish its seventh consecutive session within the pink territory after shares of the corporate declined 1.73% to $6.54 on Friday afternoon.
The vaccine maker misplaced near 13% within the earlier six periods. The autumn adopted
